| Firm | Analyst |
|---|---|
| Lake Street Capital Markets | Thomas Flaten |
| Ladenburg Thalmann & Co., Inc. | Matthew Kaplan |
| H.C. Wainwright & Co. | Joseph Pantginis, Ph.D. |
Checkpoint Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Checkpoint Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Checkpoint Therapeutics, Inc. or its management. Checkpoint Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.